Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Goossens

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 25, 2019
Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitisLorenzo A Orci, Mario Kreutzfeldt, Nicolas Goossens, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
Scientific Reports|March 4, 2017
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cellsDaniel F Hicks, Nicolas Goossens, Ana Blas-García, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Cancer Medicine|April 20, 2023
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosisChiara Rocha, Erin H Doyle, Chip A Bowman, et al.
Nature Immunology|October 27, 2015
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinomaShlomi Finkin, Detian Yuan, Ilan Stein, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Liver International : Official Journal of the International Association for the Study of the Liver|December 25, 2019
Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitisLorenzo A Orci, Mario Kreutzfeldt, Nicolas Goossens, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
Scientific Reports|March 4, 2017
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cellsDaniel F Hicks, Nicolas Goossens, Ana Blas-García, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Cancer Medicine|April 20, 2023
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosisChiara Rocha, Erin H Doyle, Chip A Bowman, et al.
Nature Immunology|October 27, 2015
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinomaShlomi Finkin, Detian Yuan, Ilan Stein, et al.
Pageof 11